Expression of SLC25A3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SLC25A3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 328.9

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

308.0

Number of samples

141

Samples

Sample	Description	TPM
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	498.9
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	455.4
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	432.4
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	427.4
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	419.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	417.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	414.3
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	412.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	411.8
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	409.2
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	407.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	403.8
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	400.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	395.0
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	392.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	390.2
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	386.7
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	384.3
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	382.0
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	381.0
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	380.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	380.2
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	377.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	373.3
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	372.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	371.6
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	368.9
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	367.4
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	364.2
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	363.4
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	361.9
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	357.8
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	355.6
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	353.4
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	351.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	351.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	348.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	348.2
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	346.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	345.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	341.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	341.6
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	340.8
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	340.7
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	339.8
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	337.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	334.9
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	332.8
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	332.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	332.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	332.3
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	330.2
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	329.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	328.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	327.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	326.4
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	323.4
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	323.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	321.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	321.2
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	319.6
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	318.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	314.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	314.0
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	311.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	310.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	310.6
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	310.1
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	308.2
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	307.5
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	307.1
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	305.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	305.2
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	303.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	303.8
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	303.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	303.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	303.1
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	301.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	300.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	299.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	296.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	296.6
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	296.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	296.2
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	294.3
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	294.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	292.6
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	291.9
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	290.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	289.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	287.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	286.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	284.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	284.0
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	279.9
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	279.7
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	278.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	277.5
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	277.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	276.3
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	274.9
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	274.8
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	274.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	271.1
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	270.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	270.2
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	268.5
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	264.2
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	263.3
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	260.5
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	259.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	259.1
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	254.9
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	252.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	247.0
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	246.5
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	246.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	245.5
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	240.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	238.7
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	237.7
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	237.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	233.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	224.0
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	222.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	221.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	221.1
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	212.7
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	211.6
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	206.1
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	201.1
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	201.0
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	192.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	189.0
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	185.7
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	171.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	169.7
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	168.6
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	154.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	81.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SLC25A3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 43.86

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

42.1

Number of samples

Samples

Sample	Description	TPM
AK156	N, NA, stage:NA, dead, 330 days	69.1
AK195	N, NA, stage:NA, dead, 390 days	63.7
AK133	N, NA, stage:NA, dead, 360 days	57.9
AK088	N, NA, stage:NA, dead, 360 days	53.7
AK068	N, NA, stage:NA, alive, 360 days	53.2
AK072	N, NA, stage:NA, dead, 150 days	53.2
AK153	N, NA, stage:NA, dead, 240 days	52.1
AK002	N, NA, stage:NA, dead, 570 days	51.9
AK185	N, NA, stage:NA, alive, 330 days	51.1
AK124	N, NA, stage:NA, alive, 1920 days	50.0
AK139	N, NA, stage:NA, dead, 270 days	48.2
AK213	N, NA, stage:NA, alive, 2010 days	47.7
AK123	N, NA, stage:NA, dead, 180 days	47.6
AK236	N, NA, stage:NA, dead, 360 days	46.8
AK142	N, NA, stage:NA, alive, 90 days	46.8
AK218	N, NA, stage:NA, dead, 180 days	45.7
AK098	N, NA, stage:NA, dead, 660 days	45.5
AK030	N, NA, stage:NA, dead, 120 days	44.5
AK173	N, NA, stage:NA, dead, 180 days	44.3
AK103	N, NA, stage:NA, alive, 1320 days	43.4
AK227	N, NA, stage:NA, alive, 300 days	42.7
AK074	N, NA, stage:NA, alive, 300 days	42.5
AK081	N, NA, stage:NA, dead, 180 days	42.4
AK066	N, NA, stage:NA, alive, 960 days	42.2
AK158	N, NA, stage:NA, dead, 360 days	41.7
AK076	N, NA, stage:NA, alive, 660 days	41.5
AK188	N, NA, stage:NA, alive, 420 days	41.4
AK099	N, NA, stage:NA, dead, 420 days	41.0
AK165	N, NA, stage:NA, alive, 360 days	41.0
AK071	N, NA, stage:NA, dead, 540 days	40.8
AK183	N, NA, stage:NA, alive, 360 days	40.8
AK051	N, NA, stage:NA, dead, 360 days	40.2
AK035	N, NA, stage:NA, dead, 210 days	40.0
AK149	N, NA, stage:NA, dead, 420 days	40.0
AK085	N, NA, stage:NA, alive, 660 days	39.7
AK043	N, NA, stage:NA, alive, 660 days	39.6
AK178	N, NA, stage:NA, dead, 240 days	39.5
AK231	N, NA, stage:NA, dead, 240 days	39.0
AK134	N, NA, stage:NA, dead, 360 days	39.0
AK079	N, NA, stage:NA, dead, 210 days	38.0
AK117	N, NA, stage:NA, dead, 210 days	37.6
AK041	N, NA, stage:NA, alive, 810 days	37.3
AK216	N, NA, stage:NA, dead, 360 days	36.4
AK049	N, NA, stage:NA, dead, 180 days	36.3
AK100	N, NA, stage:NA, alive, 960 days	36.0
AK055	N, NA, stage:NA, dead, 240 days	35.6
AK226	N, NA, stage:NA, dead, 360 days	35.5
AK053	N, NA, stage:NA, dead, 300 days	35.4
AK199	N, NA, stage:NA, alive, 1860 days	34.9
AK089	N, NA, stage:NA, dead, 330 days	34.9
AK005	N, NA, stage:NA, dead, 240 days	34.6
AK003	N, NA, stage:NA, dead, 600 days	34.5
AK015	N, NA, stage:NA, alive, 720 days	34.1
AK167	N, NA, stage:NA, dead, 180 days	32.3
AK006	N, NA, stage:NA, dead, 360 days	31.2
AK102	N, NA, stage:NA, alive, 1740 days	30.4
AK091	N, NA, stage:NA, dead, 210 days	30.2
AK205	N, NA, stage:NA, dead, 120 days	28.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204400003	Normal	1.7
CPT0204340003	Normal	1.5
CPT0204420003	Normal	1.5
CPT0204360003	Normal	1.4
CPT0204330003	Normal	1.4
CPT0204410003	Normal	1.4
CPT0204390003	Normal	1.3
CPT0204370003	Normal	1.2
CPT0204380003	Normal	1.1
CPT0204350003	Normal	0.8
CPT0224330003	Tumor	0.6
CPT0206330003	Tumor	0.5
CPT0162140003	Tumor	0.5
CPT0206880003	Tumor	0.4
CPT0199770003	Tumor	0.4
CPT0168270003	Tumor	0.3
CPT0071100003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0201710003	Tumor	0.3
CPT0221180003	Tumor	0.3
CPT0207030003	Tumor	0.3
CPT0218890004	Tumor	0.2
CPT0104330003	Tumor	0.2
CPT0218670003	Tumor	0.2
CPT0219080004	Tumor	0.1
CPT0182550003	Tumor	0.1
CPT0206110003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0217880003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0168080003	Tumor	0.0
CPT0209440003	Tumor	0.0
CPT0182580003	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0125510003	Tumor	0.0
CPT0189250003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0206560003	Tumor	-0.1
CPT0218830004	Tumor	-0.1
CPT0167860004	Tumor	-0.2
CPT0190360004	Tumor	-0.2
CPT0205570003	Tumor	-0.2
CPT0162100003	Tumor	-0.2
CPT0104220003	Tumor	-0.2
CPT0189460003	Tumor	-0.2
CPT0087950003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0225730003	Tumor	-0.2
CPT0205670004	Tumor	-0.3
CPT0125220003	Tumor	-0.3
CPT0093590003	Tumor	-0.3
CPT0218690004	Tumor	-0.3
CPT0205450004	Tumor	-0.3
CPT0190240004	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0216920008	Tumor	-0.3
CPT0206230003	Tumor	-0.3
CPT0205890003	Tumor	-0.4
CPT0125570003	Tumor	-0.4
CPT0167640003	Tumor	-0.4
CPT0225760003	Tumor	-0.4
CPT0161730003	Tumor	-0.4
CPT0224390004	Tumor	-0.4
CPT0186100003	Tumor	-0.4
CPT0196850003	Tumor	-0.4
CPT0087680003	Tumor	-0.4
CPT0127480003	Tumor	-0.4
CPT0217060003	Tumor	-0.5
CPT0168480003	Tumor	-0.5
CPT0217190003	Tumor	-0.5
CPT0167970003	Tumor	-0.5
CPT0206670004	Tumor	-0.5
CPT0217100003	Tumor	-0.5
CPT0064650003	Tumor	-0.5
CPT0206000004	Tumor	-0.5
CPT0189570004	Tumor	-0.6
CPT0093360003	Tumor	-0.6
CPT0093510003	Tumor	-0.6
CPT0168380003	Tumor	-0.6
CPT0206780003	Tumor	-0.6
CPT0175060003	Tumor	-0.6
CPT0189650004	Tumor	-0.6
CPT0224540004	Tumor	-0.6
CPT0217710008	Tumor	-0.6
CPT0218330004	Tumor	-0.6
CPT0064890003	Tumor	-0.6
CPT0087730003	Tumor	-0.6
CPT0079790003	Tumor	-0.7
CPT0127420003	Tumor	-0.7
CPT0002410011	Tumor	-0.7
CPT0167530003	Tumor	-0.7
CPT0168830003	Tumor	-0.7
CPT0207090003	Tumor	-0.7
CPT0217000004	Tumor	-0.7
CPT0123530003	Tumor	-0.8
CPT0078580003	Tumor	-0.8
CPT0093550003	Tumor	-0.8
CPT0228220003	Tumor	-0.9
CPT0218770003	Tumor	-0.9
CPT0093450003	Tumor	-0.9
CPT0217430008	Tumor	-0.9
CPT0162020003	Tumor	-1.0
CPT0087570003	Tumor	-1.1
CPT0089150003	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis